Apatinib Plus Sintilimab in Advanced Gastric Cancer Refractory to at Least Two Previous Chemotherapy Regimens

Condition:   Advanced Metastatic Gastric Cancer Interventions:   Drug: Apatinib Mesylate;   Drug: Sintilimab Sponsor:   Fujian Cancer Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials